United States of America: U.S. Administration announces deal with AstraZeneca for Most-Favoured-Nation drug pricing and temporary tariff exemptions

This Thread tracks harmful trade policy interventions affecting all products. Covering all types of interventions monitored by Global Trade Alert, it highlights how the yearly number of these measures has evolved over time.

This Thread tracks the U.S. Administration’s agreements with pharmaceutical companies. It is based on the Executive Order titled “Delivering Most-Favored-Nation (MFN) Prescription Drug Pricing to American Patients.” These agreements include tariff relief measures for pharmaceutical companies in return for their commitments to implement most-favored-nation pricing for their drugs and to invest i...

This Thread tracks harmful trade policy interventions affecting HS codes for medical consumables, equipment, medicines, vaccines, as well as chemicals used in pharmaceutical production. It covers all types of interventions monitored by Global Trade Alert since 2009. To identify relevant policy actions, the Global Trade Alert team focused on the identification of relevant HS codes following the pr...

This Thread tracks harmful trade policy interventions introduced by G7 members since 2009. It covers all types of interventions monitored by Global Trade Alert.

This Thread tracks harmful trade policy interventions introduced by G20 members since 2009. It covers all types of interventions monitored by Global Trade Alert.